FDA approves first therapy for Alexander disease
-
By
-
Kathryn Wighton
-
September 4, 2026
-
2 min
By
Kathryn Wighton
September 4, 2026
Women reported improvement across 6 cognitive domains during 12 months of estriol-based treatment, while murine models suggested a potential astrocyte-mediated mechanism.
September 3, 2026
Use is limited to level indoor and adjoining outdoor areas and requires supervision by a companion with specialized training.
August 12, 2026